Cancer/Testis Antigen Immunotherapy Phase I Study With 740-CTA Vaccinia Virus

NCT03110445 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped not sufficiently staff available to perform trial

Conditions

Breast Carcinoma

Interventions

BIOLOGICAL: rVV-740CTA

Sponsor

University Hospital, Basel, Switzerland